Sage Journals: Discover world-class research

Retricted access

Research article

First published 2005-10

Immunomodulatory Drugs (IMiDs) Increase the Production of IL-2 from Stimulated T Cells by Increasing PKC-θ Activation and Enhancing the DNA-Binding Activity of AP-1 but Not NF-κB,OCT-1,or NF-AT

Faribourz Payvandi, Lei Wu, Syedah D. Naziruddin [...]

Journal of Interferon & Cytokine Research

Open access

Research article

First published 2025

Pharmacovigilance study of immunomodulatory drug-related adverse events using spontaneous reporting system databases

Satoshi Nakao, Mika Maezawa, Moe Yamashita [...]

International Journal of Immunopathology and Pharmacology

Open access

Review article

First published 2013

Current and Emerging Treatment Options for Patients with Relapsed Myeloma

Roberto Castelli, Roberta Gualtierotti, Nicola Orofino [...]

Clinical Medicine Insights: Oncology

Open access

Research article

First published 2024

Antithrombotic utilization,adverse events,and associations with treatment outcomes in multiple myeloma: pooled analysis of three clinical trials

Sara A. Almansour, Mohammad A. Y. Alqudah, Ziad Abuhelwa [...]

Therapeutic Advances in Medical Oncology

Free access

Review article

First published 2018-7

Update on the role of lenalidomide in patients with multiple myeloma

Sarah A. Holstein, Vera J. Suman, Philip L. McCarthy

Therapeutic Advances in Hematology

Open access

Review article

First published 2009

Management of Multiple Myeloma and Myelodysplastic Syndrome: Focus on Lenalidomide

Christine Volk, Ulrike Klein

Clinical Medicine Insights: Therapeutics

Open access

Review article

First published 2020

The role of belantamab mafodotin for patients with relapsed and/or refractory multiple myeloma

Melody R. Becnel, Hans C. Lee

Therapeutic Advances in Hematology

Open access

Review article

First published 2019

Immunotherapy in myeloma: how far have we come?

Laurens E. Franssen, Tuna Mutis, Henk M. Lokhorst [...]

Therapeutic Advances in Hematology

Open access

Case report

First published 2022

Treatment-Associated Acute Lymphoblastic Leukemia Following Autologous Hematopoietic Stem Cell Transplant and Lenalidomide Maintenance in Patients With Multiple Myeloma

James Crosby, Tosha Erzuah, Mahvish Haider [...]

Journal of Investigative Medicine High Impact Case Reports

Free access

Review article

First published 2012-10

Venous and arterial thrombotic risks with thalidomide: evidence and practical guidance

Antonio Palumbo, Carmela Palladino

Therapeutic Advances in Drug Safety

Search results